Clinical Trial

Probiotic Effects in Type 2 Diabetes

Completed
View on ClinicalTrials.gov →
Summary
Adult-onset diabetes is a disease characterized by high blood glucose levels and is one of the leading causes of cardiovascular disease, blindness, end-stage renal failure, and hospitalization. Recent studies support the idea that bacteria found in the gut may play an important role in the development and progression of diabetes. Changes in the gut bacterial environment can affect blood glucose and blood lipids. A increasing number of recent studies have shown that probiotics can alter the gut bacterial environment and reduce blood glucose and blood lipids. The aim of this study is to investigate the effects of probiotics, administered in addition to your current medications, on blood glucose and blood lipids.
Trial Details
NCT Number NCT07330388
Lead Sponsor Ege University
Conditions Diabetes Mellitus (Type 2), Inflammation, Probiotics, Antioxidant Effect, Glucose Metabolism, Lipid Metabolism
Enrollment 77 participants
Start Date 2020-07-01
Primary Completion 2023-06-01 (estimated)
Study Completion 2023-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-09